PMCB — Pharmacyte Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Pharmacyte Biotech, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2019 April 30th	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.515	0.895	2.2	85.4	68
Prepaid Expenses
Total Current Assets	0.653	1.04	2.28	85.5	68.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5.78	6.17	7.4	90.6	73.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.743	1.03	0.725	0.704	0.587
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.743	1.08	0.725	0.704	0.587
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	5.04	5.09	6.68	89.9	72.7
Total Liabilities & Shareholders' Equity	5.78	6.17	7.4	90.6	73.3
Total Common Shares Outstanding